U.S. FDA Accepts AbbVie’s (ABBV) New Drug Application for Atogepant for the Preventive Treatment of Migraine

U.S. FDA Accepts AbbVie’s New Drug Application for Atogepant for the Preventive…

American Premium Water Corporation (HIPH) to Present at the Emerging Growth Conference on March 31st, 2021

American Premium Water Corp. (OTC:HIPH) to Present at the Emerging Growth Conference…